Mirikizumab is a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis. Pharmaceutical company Eli Lilly recently released findings of two studies ...
Medications for ulcerative colitis (UC) can treat and prevent flares, but they can also come with some uncomfortable side effects. For example, immunomodulators like azathioprine (Azasan) decrease UC ...
MedPage Today on MSN
Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis
In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...
Significantly more patients with moderately to severely active ulcerative colitis achieved clinical remission with the investigational monoclonal antibody tulisokibart compared with placebo, a ...
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...
Pharmaceutical company Eli Lilly recently released findings of two studies regarding the long-term efficacy and safety of mirikizumab for not only ulcerative colitis, but also Crohn’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results